Infinity Pharmaceuticals, Inc.
US ˙ OTCPK ˙ US45665G3039

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Michael Kauffman. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Michael Kauffman har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:VSTM / Verastem, Inc. Director 17.216
US:ACET / Adicet Bio, Inc. Director 5.900
US:KPTI / Karyopharm Therapeutics Inc. Director 27.000
US:KZR / Kezar Life Sciences, Inc. Director 3.896
US:INFI / Infinity Pharmaceuticals Inc. Director 30.000
US:ZLCS / Director 15.000
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Michael Kauffman. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb INFIQ / Infinity Pharmaceuticals, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i INFIQ / Infinity Pharmaceuticals, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

INFIQ / Infinity Pharmaceuticals, Inc. Insider Trades
Insidersalg INFIQ / Infinity Pharmaceuticals, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i INFIQ / Infinity Pharmaceuticals, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

INFIQ / Infinity Pharmaceuticals, Inc. Insider Trades
Insiderkøb KPTI / Karyopharm Therapeutics Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i INFIQ / Infinity Pharmaceuticals, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

KPTI / Karyopharm Therapeutics Inc. Insider Trades
Insidersalg KPTI / Karyopharm Therapeutics Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i INFIQ / Infinity Pharmaceuticals, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2022-02-28 KPTI Kauffman Michael 6.226 10,2375 415 153,5625 63.739 302 2.48 -62.709 -98,39
2022-02-17 KPTI Kauffman Michael 9.079 12,1234 605 181,8510 110.068
2022-02-17 KPTI Kauffman Michael 9.088 12,1234 606 181,8510 110.177
2022-02-07 KPTI Kauffman Michael 6.764 9,8620 451 147,9300 66.707
2022-02-07 KPTI Kauffman Michael 6.707 9,8620 447 147,9300 66.144
2021-02-18 KPTI Kauffman Michael 9.495 14,8312 633 222,4680 140.822
2021-02-18 KPTI Kauffman Michael 9.495 14,8312 633 222,4680 140.822
2021-02-11 KPTI Kauffman Michael 6.601 15,5190 440 232,7850 102.441
2021-02-11 KPTI Kauffman Michael 6.642 15,5190 443 232,7850 103.077
2020-02-19 KPTI Kauffman Michael 8.817 16,4819 588 247,2285 145.321
2020-02-19 KPTI Kauffman Michael 8.817 16,4819 588 247,2285 145.321
2015-01-12 KPTI Kauffman Michael 25.000 33,0000 1.667 495,0000 825.000
2015-01-12 KPTI Kauffman Michael 25.000 33,0000 1.667 495,0000 825.000
2014-07-02 KPTI Kauffman Michael 100.000 42,5000 6.667 637,5000 4.250.000
2014-07-02 KPTI Kauffman Michael 100.000 42,5000 6.667 637,5000 4.250.000

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

KPTI / Karyopharm Therapeutics Inc. Insider Trades
Insiderkøb KZR / Kezar Life Sciences, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i INFIQ / Infinity Pharmaceuticals, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

KZR / Kezar Life Sciences, Inc. Insider Trades
Insidersalg KZR / Kezar Life Sciences, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i INFIQ / Infinity Pharmaceuticals, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

KZR / Kezar Life Sciences, Inc. Insider Trades
Insiderkøb VSTM / Verastem, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i INFIQ / Infinity Pharmaceuticals, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2018-09-28 VSTM Kauffman Michael 4.000 7,4900 333 89,8800 29.960 0 1044 317.692 1.060,39
2014-09-17 VSTM Kauffman Michael 3.000 9,0999 250 109,1988 27.300

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

VSTM / Verastem, Inc. Insider Trades
Insidersalg VSTM / Verastem, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i INFIQ / Infinity Pharmaceuticals, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2015-08-24 VSTM Kauffman Michael 2.070 6,4610 172 77,5320 13.374 168 158.4 13.871 103,71
2015-03-19 VSTM Kauffman Michael 930 10,9590 78 131,5080 10.192

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

VSTM / Verastem, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Michael Kauffman som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-05-27 2025-05-22 4 VSTM Verastem, Inc.
Common Stock
A - Award 8.333 17.216 93,81
2024-06-20 2024-06-18 4 VSTM Verastem, Inc.
Common Stock
A - Award 8.333 8.883 1.515,09
2024-06-07 2024-06-05 4 ACET Adicet Bio, Inc.
Common Stock
S - Sale -5.900 5.900 -50,00 1,43 -8.437 8.437
2024-06-07 2024-06-05 4 ACET Adicet Bio, Inc.
Common Stock
A - Award 5.900 11.800 100,00
2023-06-02 2023-06-01 4 ACET Adicet Bio, Inc.
Common Stock
A - Award 5.900 5.900
2022-03-02 2022-02-28 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
A - Award 27.000 27.000
2022-03-02 2022-02-28 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale -6.226 898.131 -0,69 10,24 -63.739 9.194.616
2022-03-02 2022-02-28 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale -6.226 713.757 -0,86 10,24 -63.739 7.307.087
2022-03-02 2022-02-28 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
A - Award 21.000 719.983 3,00
2022-02-22 2022-02-17 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale -9.088 904.357 -0,99 12,12 -110.177 10.963.882
2022-02-22 2022-02-17 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale -9.079 698.983 -1,28 12,12 -110.068 8.474.051
2022-02-09 2022-02-07 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale -6.707 913.445 -0,73 9,86 -66.144 9.008.395
2022-02-09 2022-02-07 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale -6.764 708.062 -0,95 9,86 -66.707 6.982.907
2022-01-05 2022-01-03 4 KZR Kezar Life Sciences, Inc.
Stock Option (Right to Buy)
M - Exercise -5.000 3.896 -56,21
2022-01-05 2022-01-03 4 KZR Kezar Life Sciences, Inc.
Common Stock
S - Sale X -5.000 63.690 -7,28 16,45 -82.250 1.047.700
2022-01-05 2022-01-03 4 KZR Kezar Life Sciences, Inc.
Common Stock
M - Exercise 5.000 68.690 7,85 5,91 29.550 405.958
2021-11-18 2021-11-17 4 ACET Adicet Bio, Inc.
Stock Option (right to Buy)
A - Award 37.000 37.000
2021-06-30 2021-06-28 4 VSTM Verastem, Inc.
Stock Option (right to buy)
A - Award 25.000 25.000
2021-06-30 2021-06-28 4 KZR Kezar Life Sciences, Inc.
Stock Option (Right to Buy)
A - Award 26.000 26.000
2021-03-23 2021-03-18 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -4.000 714.826 -0,56 12,39 -49.553 8.855.407
2021-03-01 2021-02-25 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
A - Award 153.500 153.500
2021-03-01 2021-02-25 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
A - Award 153.500 153.500
2021-03-01 2021-02-25 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
A - Award 57.200 920.152 6,63
2021-03-01 2021-02-25 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
A - Award 57.200 920.152 6,63
2021-02-22 2021-02-18 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale -9.495 776.452 -1,21 14,83 -140.822 11.515.715
2021-02-22 2021-02-18 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale -9.495 776.452 -1,21 14,83 -140.822 11.515.715
2021-02-17 2021-02-15 4 KPTI Karyopharm Therapeutics Inc.
Restricted Stock Units
M - Exercise -21.800 43.600 -33,33
2021-02-17 2021-02-15 4 KPTI Karyopharm Therapeutics Inc.
Restricted Stock Units
M - Exercise -21.800 43.600 -33,33
2021-02-17 2021-02-15 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise 21.800 785.947 2,85
2021-02-17 2021-02-15 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise 21.800 785.947 2,85
2021-02-17 2021-02-11 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale -6.642 764.147 -0,86 15,52 -103.077 11.858.797
2021-02-17 2021-02-11 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale -6.601 562.821 -1,16 15,52 -102.441 8.734.419
2021-02-09 2021-02-05 4 KPTI Karyopharm Therapeutics Inc.
Restricted Stock Units
M - Exercise -14.300 42.900 -25,00
2021-02-09 2021-02-05 4 KPTI Karyopharm Therapeutics Inc.
Restricted Stock Units
M - Exercise -14.300 42.900 -25,00
2021-02-09 2021-02-05 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise 14.300 770.789 1,89
2021-02-09 2021-02-05 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise 14.300 770.789 1,89
2020-10-14 2020-10-12 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -6.076 0 -100,00
2020-10-14 2020-10-12 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -1.424 0 -100,00
2020-10-14 2020-10-12 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -7.500 756.489 -0,98 14,89 -111.682 11.264.878
2020-10-14 2020-10-12 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise X 6.076 763.989 0,80 0,03 201 25.212
2020-10-14 2020-10-12 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise X 1.424 757.913 0,19 0,03 47 25.011
2020-08-18 2020-08-17 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -1.477 6.076 -19,56
2020-08-18 2020-08-17 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -1.477 756.489 -0,19 15,00 -22.155 11.347.335
2020-08-18 2020-08-17 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise X 1.477 757.966 0,20 0,03 49 25.013
2020-07-17 2020-07-15 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -7.500 1.424 -84,04
2020-07-17 2020-07-15 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -7.500 756.489 -0,98 19,43 -145.723 14.698.354
2020-07-17 2020-07-15 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise X 7.500 763.989 0,99 0,03 248 25.212
2020-07-13 2020-07-10 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -7.500 333.561 -2,20
2020-07-13 2020-07-10 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -300 555.122 -0,05 19,71 -5.912 10.939.623
2020-07-13 2020-07-10 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -7.200 555.422 -1,28 18,98 -136.627 10.539.688
2020-07-13 2020-07-10 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise X 7.500 562.622 1,35 4,75 35.640 2.673.580
2020-07-13 2020-07-09 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -7.500 377.803 -1,95
2020-07-13 2020-07-09 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -7.500 756.489 -0,98 19,53 -146.487 14.775.441
2020-07-13 2020-07-09 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise X 7.500 763.989 0,99 4,75 35.640 3.630.476
2020-06-26 2020-06-24 4 KZR Kezar Life Sciences, Inc.
Stock Option (Right to Buy)
A - Award 8.896 8.896
2020-06-24 2020-06-22 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -7.500 8.924 -45,66
2020-06-24 2020-06-22 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -7.500 756.489 -0,98 20,00 -150.000 15.129.780
2020-06-24 2020-06-22 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise X 7.500 763.989 0,99 0,03 248 25.212
2020-06-18 2020-06-16 4 VSTM Verastem, Inc.
Stock Option (Right to Buy)
A - Award 25.000 25.000
2020-06-17 2020-06-15 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -357 0 -100,00
2020-06-17 2020-06-15 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -7.143 16.424 -30,31
2020-06-17 2020-06-15 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -357 756.489 -0,05 16,20 -5.783 12.255.122
2020-06-17 2020-06-15 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise X 357 756.846 0,05 0,03 12 24.976
2020-06-17 2020-06-15 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -7.143 756.489 -0,94 16,38 -116.996 12.390.609
2020-06-17 2020-06-15 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise X 7.143 763.632 0,94 0,03 236 25.200
2020-06-11 2020-06-10 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -7.500 341.061 -2,15
2020-06-11 2020-06-10 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -7.500 555.122 -1,33 18,13 -135.944 10.062.086
2020-06-11 2020-06-10 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise X 7.500 562.622 1,35 4,75 35.640 2.673.580
2020-06-11 2020-06-09 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -7.500 385.303 -1,91
2020-06-11 2020-06-09 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -7.500 756.489 -0,98 18,50 -138.746 13.994.593
2020-06-11 2020-06-09 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise X 7.500 763.989 0,99 4,75 35.640 3.630.476
2020-05-19 2020-05-18 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -7.500 357 -95,46
2020-05-19 2020-05-18 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -7.500 756.489 -0,98 20,00 -150.000 15.129.780
2020-05-19 2020-05-18 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise X 7.500 763.989 0,99 0,03 248 25.212
2020-05-19 2020-05-15 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -7.500 7.857 -48,84
2020-05-19 2020-05-15 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -7.500 756.489 -0,98 18,65 -139.840 14.105.040
2020-05-19 2020-05-15 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise X 7.500 763.989 0,99 0,03 248 25.212
2020-05-11 2020-05-07 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -7.500 392.803 -1,87
2020-05-11 2020-05-07 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -7.500 392.803 -1,87
2020-05-11 2020-05-07 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -7.500 756.489 -0,98 19,63 -147.205 14.847.837
2020-05-11 2020-05-07 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise X 7.500 763.989 0,99 4,75 35.640 3.630.476
2020-05-11 2020-05-07 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise X 7.500 763.989 0,99 4,75 35.640 3.630.476
2020-05-11 2020-05-07 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -7.500 555.122 -1,33 19,63 -147.209 10.895.879
2020-04-10 2020-04-09 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -10.000 356.061 -2,73
2020-04-10 2020-04-09 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -10.000 555.122 -1,77 20,64 -206.404 11.457.940
2020-04-10 2020-04-09 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise X 10.000 565.122 1,80 4,75 47.520 2.685.460
2020-04-10 2020-04-08 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -10.000 400.303 -2,44
2020-04-10 2020-04-08 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -10.000 756.489 -1,30 18,61 -186.115 14.079.395
2020-04-10 2020-04-08 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise X 10.000 766.489 1,32 4,75 47.520 3.642.356
2020-03-11 2020-03-10 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -10.000 366.061 -2,66
2020-03-11 2020-03-10 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -2.068 555.122 -0,37 22,64 -46.821 12.568.240
2020-03-11 2020-03-10 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -7.932 557.190 -1,40 22,11 -175.365 12.318.691
2020-03-11 2020-03-10 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise X 10.000 565.122 1,80 4,75 47.520 2.685.460
2020-03-11 2020-03-09 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -10.000 410.303 -2,38
2020-03-11 2020-03-09 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -3.000 756.489 -0,40 22,38 -67.141 16.930.451
2020-03-11 2020-03-09 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -7.000 759.489 -0,91 22,58 -158.054 17.148.578
2020-03-11 2020-03-09 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise X 10.000 766.489 1,32 4,75 47.520 3.642.356
2020-02-21 2020-02-19 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale -8.817 756.489 -1,15 16,48 -145.321 12.468.376
2020-02-21 2020-02-19 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale -8.817 555.122 -1,56 16,48 -145.321 9.149.465
2020-02-19 2020-02-15 4 KPTI Karyopharm Therapeutics Inc.
Restricted Stock Units
M - Exercise -21.800 65.400 -25,00
2020-02-19 2020-02-15 4 KPTI Karyopharm Therapeutics Inc.
Restricted Stock Units
M - Exercise -21.800 65.400 -25,00
2020-02-19 2020-02-15 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise 21.800 765.306 2,93
2020-02-19 2020-02-15 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise 21.800 765.306 2,93
2020-02-12 2020-02-11 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -10.000 376.061 -2,59
2020-02-12 2020-02-11 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -10.000 542.139 -1,81 17,43 -174.294 9.449.157
2020-02-12 2020-02-11 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise X 10.000 552.139 1,84 4,75 47.520 2.623.765
2020-02-12 2020-02-10 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -10.000 420.303 -2,32
2020-02-12 2020-02-10 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -10.000 743.506 -1,33 16,93 -169.327 12.589.564
2020-02-12 2020-02-10 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise X 10.000 753.506 1,34 4,75 47.520 3.580.661
2020-02-07 2020-02-05 4 KPTI Karyopharm Therapeutics Inc.
Restricted Stock Units
A - Award 57.200 57.200
2020-02-07 2020-02-05 4 KPTI Karyopharm Therapeutics Inc.
Restricted Stock Units
A - Award 57.200 57.200
2020-02-07 2020-02-05 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
A - Award 153.500 153.500
2020-02-07 2020-02-05 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
A - Award 153.500 153.500
2020-01-10 2020-01-09 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -10.000 386.061 -2,52
2020-01-10 2020-01-09 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -10.000 542.139 -1,81 19,19 -191.880 10.402.563
2020-01-10 2020-01-09 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise X 10.000 552.139 1,84 4,75 47.520 2.623.765
2020-01-10 2020-01-08 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -10.000 430.303 -2,27
2020-01-10 2020-01-08 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -10.000 743.506 -1,33 18,57 -185.705 13.807.278
2020-01-10 2020-01-08 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise X 10.000 753.506 1,34 4,75 47.520 3.580.661
2020-01-10 2019-12-19 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
G - Gift -17.313 0 -100,00
2020-01-10 2019-12-19 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
G - Gift -17.313 0 -100,00
2019-12-11 2019-12-10 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -10.000 396.061 -2,46
2019-12-11 2019-12-10 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -10.000 529.767 -1,85 15,99 -159.896 8.470.762
2019-12-11 2019-12-10 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise X 10.000 539.767 1,89 4,75 47.520 2.564.973
2019-12-11 2019-12-09 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -10.000 440.303 -2,22
2019-12-11 2019-12-09 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -10.000 731.134 -1,35 17,02 -170.210 12.444.632
2019-12-11 2019-12-09 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise X 10.000 741.134 1,37 4,75 47.520 3.521.869
2019-11-12 2019-11-11 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -10.000 406.061 -2,40
2019-11-12 2019-11-11 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -10.000 529.767 -1,85 14,76 -147.610 7.819.891
2019-11-12 2019-11-11 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise X 10.000 539.767 1,89 4,75 47.520 2.564.973
2019-11-12 2019-11-08 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -10.000 450.303 -2,17
2019-11-12 2019-11-08 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -10.000 731.134 -1,35 14,63 -146.254 10.693.127
2019-11-12 2019-11-08 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise X 10.000 741.134 1,37 4,75 47.520 3.521.869
2019-11-05 2019-11-01 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -10.000 460.303 -2,13
2019-11-05 2019-11-01 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -10.000 460.303 -2,13
2019-11-05 2019-11-01 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -10.000 731.134 -1,35 12,00 -120.000 8.773.608
2019-11-05 2019-11-01 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -10.000 731.134 -1,35 12,00 -120.000 8.773.608
2019-11-05 2019-11-01 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise X 10.000 741.134 1,37 4,75 47.520 3.521.869
2019-11-05 2019-11-01 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise X 10.000 741.134 1,37 4,75 47.520 3.521.869
2019-09-17 2019-09-16 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -10.000 470.303 -2,08
2019-09-17 2019-09-16 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -10.000 470.303 -2,08
2019-09-17 2019-09-16 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -10.000 731.134 -1,35 12,00 -120.000 8.773.608
2019-09-17 2019-09-16 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -10.000 731.134 -1,35 12,00 -120.000 8.773.608
2019-09-17 2019-09-16 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise X 10.000 741.134 1,37 4,75 47.520 3.521.869
2019-09-17 2019-09-16 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise X 10.000 741.134 1,37 4,75 47.520 3.521.869
2019-06-27 2019-06-25 4 KZR Kezar Life Sciences, Inc.
Stock Option (Right to Buy)
A - Award 8.896 8.896
2019-06-25 2019-06-21 4 VSTM Verastem, Inc.
Stock Option (Right to Buy)
A - Award 25.000 25.000
2019-06-14 2019-06-13 4 INFI INFINITY PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 30.000 30.000
2019-02-19 2019-02-15 4 KPTI Karyopharm Therapeutics Inc.
Restricted Stock Units
A - Award 87.200 87.200
2019-02-19 2019-02-15 4 KPTI Karyopharm Therapeutics Inc.
Restricted Stock Units
A - Award 87.200 87.200
2019-02-19 2019-02-15 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
A - Award 231.200 231.200
2019-02-19 2019-02-15 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
A - Award 231.200 231.200
2019-02-13 2018-06-11 5 VSTM Verastem, Inc.
Stock Option (Right to Buy)
A - Award 25.000 25.000
2019-01-09 2019-01-07 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -12.500 15.357 -44,87
2019-01-09 2019-01-07 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -12.500 731.134 -1,68 10,23 -127.824 7.476.503
2019-01-09 2019-01-07 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise X 12.500 743.634 1,71 0,03 412 24.540
2018-12-10 2018-12-07 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -12.500 27.857 -30,97
2018-12-10 2018-12-07 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -12.500 713.510 -1,72 10,11 -126.422 7.216.297
2018-12-10 2018-12-07 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise X 12.500 726.010 1,75 0,03 412 23.958
2018-11-27 2018-11-26 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -9.600 436.061 -2,15
2018-11-27 2018-11-26 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -9.600 512.143 -1,84 11,00 -105.600 5.633.573
2018-11-27 2018-11-26 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise X 9.600 521.743 1,87 4,75 45.619 2.479.323
2018-11-21 2018-11-19 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -400 445.661 -0,09
2018-11-21 2018-11-19 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -400 512.143 -0,08 11,14 -4.455 5.703.378
2018-11-21 2018-11-19 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise X 400 512.543 0,08 4,75 1.901 2.435.604
2018-11-09 2018-11-07 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -12.500 40.357 -23,65
2018-11-09 2018-11-07 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -12.500 713.510 -1,72 11,65 -145.592 8.310.536
2018-11-09 2018-11-07 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise X 12.500 726.010 1,75 0,03 412 23.958
2018-10-22 2018-10-18 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -10.000 446.061 -2,19
2018-10-22 2018-10-18 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -10.000 512.143 -1,92 12,63 -126.304 6.468.571
2018-10-22 2018-10-18 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise X 10.000 522.143 1,95 4,75 47.520 2.481.224
2018-10-09 2018-10-08 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -10.736 52.857 -16,88
2018-10-09 2018-10-08 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -1.764 0 -100,00
2018-10-09 2018-10-08 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -6.000 713.510 -0,83 16,13 -96.767 11.507.347
2018-10-09 2018-10-08 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -6.500 719.510 -0,90 15,39 -100.066 11.076.641
2018-10-09 2018-10-08 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise X 10.736 726.010 1,50 0,03 354 23.958
2018-10-09 2018-10-08 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise X 1.764 715.274 0,25 0,03 58 23.604
2018-10-02 2018-09-28 4 VSTM Verastem, Inc.
Common Stock
A - Award 4.000 8.000 100,00
2018-10-02 2018-09-28 4 VSTM Verastem, Inc.
Common Stock
P - Purchase 4.000 4.000 7,49 29.960 29.960
2018-09-18 2018-09-18 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -10.000 456.061 -2,15
2018-09-18 2018-09-18 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -10.000 512.143 -1,92 18,26 -182.615 9.352.499
2018-09-18 2018-09-18 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise X 10.000 522.143 1,95 4,75 47.520 2.481.224
2018-09-10 2018-09-07 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -12.500 1.764 -87,63
2018-09-10 2018-09-07 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -12.500 713.510 -1,72 19,31 -241.384 13.778.378
2018-09-10 2018-09-07 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise X 12.500 726.010 1,75 0,03 412 23.958
2018-08-21 2018-08-20 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -10.000 466.061 -2,10
2018-08-21 2018-08-20 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -10.000 512.143 -1,92 17,46 -174.568 8.940.378
2018-08-21 2018-08-20 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise X 10.000 522.143 1,95 4,75 47.520 2.481.224
2018-08-08 2018-08-07 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -12.500 14.264 -46,70
2018-08-08 2018-08-07 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -12.500 713.510 -1,72 18,04 -225.556 12.874.931
2018-08-08 2018-08-07 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise X 12.500 726.010 1,75 0,03 412 23.958
2018-07-20 2018-07-18 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -4.242 476.061 -0,88
2018-07-20 2018-07-18 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -5.757 0 -100,00
2018-07-20 2018-07-18 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -1 0 -100,00
2018-07-20 2018-07-18 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -10.000 512.143 -1,92 18,27 -182.686 9.356.136
2018-07-20 2018-07-18 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise X 4.242 522.143 0,82 4,75 20.158 2.481.224
2018-07-20 2018-07-18 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise X 5.757 517.901 1,12 0,26 1.520 136.726
2018-07-20 2018-07-18 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise X 1 512.144 0,00 0,03 0 16.901
2018-07-10 2018-07-09 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -12.500 26.764 -31,84
2018-07-10 2018-07-09 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -12.500 713.510 -1,72 18,72 -233.990 13.356.336
2018-07-10 2018-07-09 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise X 12.500 726.010 1,75 0,03 412 23.958
2018-06-27 2018-06-25 4 KZR Kezar Life Sciences, Inc.
Series A Convertible Preferred Stock
C - Conversion -10.516 0 -100,00
2018-06-27 2018-06-25 4 KZR Kezar Life Sciences, Inc.
Common Stock
C - Conversion 10.516 63.690 19,78
2018-06-20 3 KZR Kezar Life Sciences, Inc.
Common Stock
106.348
2018-06-20 3 KZR Kezar Life Sciences, Inc.
Common Stock
106.348
2018-06-20 3 KZR Kezar Life Sciences, Inc.
Common Stock
106.348
2018-06-19 2018-06-18 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -10.000 5.757 -63,46
2018-06-19 2018-06-18 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -10.000 512.143 -1,92 18,66 -186.558 9.554.437
2018-06-19 2018-06-18 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise X 10.000 522.143 1,95 0,26 2.640 137.846
2018-06-14 2018-06-12 4 INFI INFINITY PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 20.000 20.000
2018-06-11 2018-06-07 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -303 7.553 -3,86
2018-06-11 2018-06-07 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -9.697 0 -100,00
2018-06-11 2018-06-07 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -10.000 713.510 -1,38 17,30 -172.991 12.343.081
2018-06-11 2018-06-07 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise X 303 723.510 0,04 0,03 10 23.876
2018-06-11 2018-06-07 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise X 9.697 723.207 1,36 0,26 2.560 190.927
2018-05-21 2018-05-18 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -10.000 15.757 -38,82
2018-05-21 2018-05-18 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -10.000 512.143 -1,92 19,39 -193.870 9.928.916
2018-05-21 2018-05-18 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise X 10.000 522.143 1,95 0,26 2.640 137.846
2018-05-08 2018-05-07 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -10.000 9.697 -50,77
2018-05-08 2018-05-07 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -10.000 713.510 -1,38 16,77 -167.747 11.968.916
2018-05-08 2018-05-07 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise X 10.000 723.510 1,40 0,26 2.640 191.007
2018-04-20 2018-04-18 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -7.576 18.181 -29,41
2018-04-20 2018-04-18 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -2.424 0 -100,00
2018-04-20 2018-04-18 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -10.000 512.143 -1,92 14,79 -147.878 7.573.468
2018-04-20 2018-04-18 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise X 10.000 522.143 1,95 0,26 2.640 137.846
2018-04-10 2018-04-09 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -10.000 19.697 -33,67
2018-04-10 2018-04-09 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -10.000 713.510 -1,38 12,48 -124.829 8.906.674
2018-04-10 2018-04-09 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise X 10.000 723.510 1,40 0,26 2.640 191.007
2018-03-20 2018-03-19 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -10.000 2.424 -80,49
2018-03-20 2018-03-19 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -10.000 512.143 -1,92 15,29 -152.895 7.830.410
2018-03-20 2018-03-19 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise X 10.000 522.143 1,95 0,26 2.640 137.846
2018-03-08 2018-03-07 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -606 29.697 -2,00
2018-03-08 2018-03-07 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -9.394 0 -100,00
2018-03-08 2018-03-07 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -10.000 713.510 -1,38 16,15 -161.463 11.520.547
2018-03-08 2018-03-07 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise X 10.000 723.510 1,40 0,26 2.640 191.007
2018-02-22 2018-02-20 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -10.000 12.424 -44,60
2018-02-22 2018-02-20 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -10.000 512.143 -1,92 14,79 -147.872 7.573.161
2018-02-22 2018-02-20 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise X 10.000 522.143 1,95 0,26 2.640 137.846
2018-02-08 2018-02-07 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -10.000 9.394 -51,56
2018-02-08 2018-02-07 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -10.000 713.510 -1,38 12,50 -125.048 8.922.300
2018-02-08 2018-02-07 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise X 10.000 723.510 1,40 0,26 2.640 191.007
2018-01-25 2018-01-24 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
A - Award 200.000 200.000
2018-01-25 2018-01-24 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
A - Award 200.000 200.000
2018-01-22 2018-01-18 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -10.000 22.424 -30,84
2018-01-22 2018-01-18 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -10.000 512.143 -1,92 10,09 -100.882 5.166.601
2018-01-22 2018-01-18 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise X 10.000 522.143 1,95 0,26 2.640 137.846
2018-01-09 2018-01-08 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -10.000 19.394 -34,02
2018-01-09 2018-01-08 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -10.000 713.510 -1,38 10,08 -100.769 7.189.969
2018-01-09 2018-01-08 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise X 10.000 723.510 1,40 0,26 2.640 191.007
2017-12-20 2017-12-18 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -10.000 32.424 -23,57
2017-12-20 2017-12-18 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -10.000 512.143 -1,92 9,16 -91.553 4.688.823
2017-12-20 2017-12-18 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise X 10.000 522.143 1,95 0,26 2.640 137.846
2017-12-08 2017-12-07 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
M - Exercise X -10.000 29.394 -25,38
2017-12-08 2017-12-07 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -10.000 713.510 -1,38 10,39 -103.903 7.413.583
2017-12-08 2017-12-07 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
M - Exercise X 10.000 723.510 1,40 0,26 2.640 191.007
2017-06-15 2017-06-13 4 VSTM Verastem, Inc.
Stock Option (Right to Buy)
A - Award 25.000 25.000
2017-04-06 2017-04-05 4 INFI INFINITY PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 40.000 40.000
2017-01-24 2017-01-20 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
A - Award 250.000 250.000
2017-01-24 2017-01-20 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
A - Award 250.000 250.000
2016-06-16 2016-06-14 4 VSTM Verastem, Inc.
Stock Option (Right to Buy)
A - Award 25.000 25.000
2016-02-17 2015-08-24 4 VSTM Verastem, Inc.
Common Stock
S - Sale -2.070 0 -100,00 6,46 -13.374
2016-02-17 2015-03-19 4 VSTM Verastem, Inc.
Common Stock
S - Sale -930 2.070 -31,00 10,96 -10.192 22.685
2016-02-12 2015-12-30 5 KPTI Karyopharm Therapeutics Inc.
Common Stock
G - Gift -3.144 760.819 -0,41
2016-02-12 2015-12-30 5 KPTI Karyopharm Therapeutics Inc.
Common Stock
G - Gift -3.144 559.452 -0,56
2016-01-20 2016-01-15 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
A - Award 170.000 170.000
2016-01-20 2016-01-15 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
A - Award 170.000 170.000
2015-06-16 2015-06-12 4 VSTM Verastem, Inc.
Stock Option (Right to Buy)
A - Award 17.969 17.969
2015-01-22 2015-01-19 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
A - Award 200.000 200.000
2015-01-22 2015-01-19 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
A - Award 200.000 200.000
2015-01-14 2015-01-12 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale -25.000 763.963 -3,17 33,00 -825.000 25.210.779
2015-01-14 2015-01-12 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale -25.000 562.596 -4,25 33,00 -825.000 18.565.668
2015-01-14 2014-12-01 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
G - Gift -20.000 788.963 -2,47
2014-09-18 2014-09-17 4 VSTM Verastem, Inc.
Common Stock
P - Purchase 3.000 3.000 9,10 27.300 27.300
2014-07-02 2014-07-02 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale -100.000 808.963 -11,00 42,50 -4.250.000 34.380.928
2014-07-02 2014-07-02 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale -100.000 808.963 -11,00 42,50 -4.250.000 34.380.928
2014-06-19 2014-06-18 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -10.000 687.596 -1,43 43,15 -431.523 29.671.349
2014-06-19 2014-06-17 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
S - Sale X -10.000 908.963 -1,09 40,36 -403.635 36.688.928
2014-06-11 2014-06-10 4 VSTM Verastem, Inc.
Stock Option (Right to Buy)
A - Award 25.000 25.000
2014-02-14 2013-12-20 5 KPTI Karyopharm Therapeutics Inc.
Common Stock
G - Gift -82.750 918.963 -8,26
2014-02-14 2013-12-20 5 KPTI Karyopharm Therapeutics Inc.
Common Stock
G - Gift -55.750 697.596 -7,40
2013-12-20 2013-12-18 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
A - Award 140.000 140.000
2013-12-20 2013-12-18 4 KPTI Karyopharm Therapeutics Inc.
Stock Option (right to buy)
A - Award 140.000 140.000
2013-11-13 2013-11-12 4 KPTI Karyopharm Therapeutics Inc.
Series A Convertible Preferred Stock
C - Conversion -132.575 0 -100,00
2013-11-13 2013-11-12 4 KPTI Karyopharm Therapeutics Inc.
Common Stock
C - Conversion 132.575 753.346 21,36
2013-11-05 3 KPTI Karyopharm Therapeutics Inc.
Common Stock
620.771
2013-11-05 3 KPTI Karyopharm Therapeutics Inc.
Common Stock
1.001.713
2013-06-10 2013-06-06 4 ZLCS Zalicus Inc.
Non-Qualified Stock Option (right to buy)
A - Award 15.000 15.000
2013-06-06 2013-06-04 4 VSTM Verastem, Inc.
Stock Option (Right to Buy)
A - Award 6.507 6.507
2013-06-06 2013-06-04 4 VSTM Verastem, Inc.
Stock Option (Right to Buy)
A - Award 12.500 12.500
2012-11-27 2012-11-26 4 VSTM Verastem, Inc.
Stock Option (Right to Buy)
A - Award 25.000 25.000
2012-05-25 2012-05-23 4 ZLCS Zalicus Inc.
Non-Qualified Stock Option (right to buy)
A - Award 15.000 15.000
2006-06-05 3 CRXX COMBINATORX, INC
None
0
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)